Disease-associated gut microbiota involvement and its mechanisms in the lung injury

doi:10.16352/j.issn.1001-6325.2025.05.0681

Abstract

Abstract: The gut microbiota is generally thought in regulating the body′s metabolism and immune function. The imbalance of gut microbiota is related to the occurrence and development mechanisms of acute and chronic lung diseases, resulting from lung injury. The “gut-lung axis” pays a main role in various ways in the occurrence of lung injury, including intestinal barrier dysfunction, reduced diversity of gut microbiota, decreased secretion of beneficial metabolites, translocation of gut microbiota and metabolites to the lungs, immune damage to the body and lungs, increased inflammatory response in the lungs.

Key words: gut microbiota, lung injury, immunity, perioperative

CLC Number:

ZHU Qianmei, LI Qingyang, CHE Lu, HUANG Yuguang. Disease-associated gut microbiota involvement and its mechanisms in the lung injury[J]. Basic & Clinical Medicine, 2025, 45(5): 681-685.

References

[1]de Vos WM, Tilg H, Van Hul M, et al. Gut microbiome and health: mechanistic insights[J]. Gut, 2022, 71:1020-1032. doi: 10.1136/gutjnl-2021-326789.
[2]Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease[J]. Cell Microbiol, 2014, 16:1024-33. doi: 10.1111/cmi.12308.
[3]邵瑞飞,杨艳,郑志榕,等. 肠道菌群和“肠-肺”轴在脓毒症中的作用[J]. 基础医学与临床,2020, 40:1109-1112.
[4]Mo M, Wang J, Gu H, et al. Intestinal microbes-based analysis of immune mechanism of childhood asthma[J]. Cell Mol Biol (Noisy-le-grand), 2022, 68:70-80. doi: 10.14715/cmb/2022.68.2.11.
[5]Liu Y, Liu J, Du M, et al. Short-chain fatty acid-A critical interfering factor for allergic diseases[J]. Chem Biol Interact, 2023, 385:110739. doi: 10.1016/j.cbi.2023.110739.
[6]Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis[J]. Nat Med, 2014, 20:159-66. doi: 10.1038/nm.3444.
[7]Guryanova SV. Bacteria and allergic diseases[J]. Int J Mol Sci, 2024, 25:10298. doi: 10.3390/ijms251910298.
[8]Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease[J]. Respir Res, 2021, 22:274. doi: 10.1186/s12931-021-01872-z.
[9]Bowerman KL, Rehman SF, Vaughan A, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease[J]. Nat Commun, 2020, 11:5886. doi: 10.1038/s41467-020-19701-0.
[10]Fluhr L, Mor U, Kolodziejczyk AA, et al. Gut microbiota modulates weight gain in mice after discontinued smoke exposure[J]. Nature, 2021, 600:713-719. doi: 10.1038/s41586-021-04194-8.
[11]D'amico F, Baumgart DC, Danese S, et al. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management[J]. Clin Gastroenterol Hepatol, 2020, 18:1663-1672. doi: 10.1016/j.cgh.2020.04.001.
[12]Sencio V, Machado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes[J]. Mucosal Immunol, 2021, 14:296-304. doi: 10.1038/s41385-020-00361-8.
[13]Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling[J]. Nat Commun, 2017, 8:1512. doi: 10.1038/s41467-017-01803-x.
[14]Galvão I, Tavares LP, Corrêa RO, et al. The metabolic sensor GPR43 receptor plays a role in the control of klebsiella pneumoniae infection in the lung[J]. Front Immunol, 2018, 9:142. doi: 10.3389/fimmu.2018.00142.
[15]Zhang DW, Lu JL, Dong BY, et al. Gut microbiota and its metabolic products in acute respiratory distress syndrome[J]. Front Immunol, 2024, 15:1330021. doi: 10.3389/fimmu.2024.1330021.
[16]Dickson RP, Singer BH, Newstead MW, et al. Enrich-ment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome[J]. Nat Microbiol, 2016, 1:16113. doi: 10.1038/nmicrobiol.2016.113.
[17]Althouse MH, Stewart C, Jiang W, et al. Impact of early life antibiotic exposure and neonatal hyperoxia on the murine microbiome and lung injury[J]. Sci Rep, 2019, 9:14992. doi: 10.1038/s41598-019-51506-0.
[18]Wedgwood S, Warford C, Agvatisiri SR, et al. The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model[J]. Pediatr Res, 2020, 87:472-479. doi: 10.1038/s41390-019-0578-2.
[19]Chen CM, Chou HC, Yang YSH, et al. Predicting hyperoxia-induced lung injury from associated intestinal and lung dysbiosis in neonatal mice[J]. Neonatology, 2021, 118:163-173. doi: 10.1159/000513553.
[20]Abdelgawad A, Nicola T, Martin I, et al. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota[J]. Microbiome, 2023, 11:226. doi: 10.1186/s40168-023-01673-0.
[21]Chen CM, Yang YSH, Chou HC. Maternal antibiotic exposure disrupts microbiota and exacerbates hyperoxia-induced lung injury in neonatal mice[J]. Pediatr Res, 2021, 90:776-783. doi: 10.1038/s41390-020-01335-z.
[22]Zhang J, Bi J, Ren Y, et al. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice[J]. Cytokine, 2018, 111:237-245. doi: 10.1016/j.cyto.2018.08.032.
[23]Wang YH, Yan ZZ, Luo SD, et al. Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice[J]. Eur Respir J, 2023, 61:2200840. doi: 10.1183/13993003.00840-2022.
[24]Kapur R, Kim M, Rebetz J, et al. Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury[J]. Blood Adv, 2018, 2:1651-1663. doi: 10.1182/bloodadvances.2018018903.
[25]Tian Z, Wu E, You J, et al. Dynamic alterations in the lung microbiota in a rat model of lipopolysaccharide-induced acute lung injury[J]. Sci Rep, 2022, 12:4791. doi: 10.1038/s41598-022-08831-8.
[26]Serbanescu MA, Mathena RP, Xu J, et al. General anesthesia alters the diversity and composition of the intestinal microbiota in mice[J]. Anesth Analg, 2019, 129:e126-e129. doi: 10.1213/ANE.0000000000003938.